← Leaderboards
Daifeng Wang
Icahn School Of Medicine At Mount Sinai
$4,934,175
Attributed
$14,410,550
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2019–23$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$14,410,550 · 6
By mechanism
R01$11,523,662 · 1
RF1$1,219,630 · 1
R21$1,202,833 · 3
R03$464,425 · 1
Top collaborators
- Steven M Finkbeiner11 shared
- Vahram Haroutunian11 shared
- Panagiotis Roussos11 shared
- John P Svaren3 shared
- Kimberly Anne Aldinger2 shared
- Flaminia Talos2 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Jianlong Wang$10,059,386
- Nihal Mohamed$3,339,381
- Panagiotis Roussos$45,081,240
- Vahram Haroutunian$39,970,462
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMolecularData SetCellsCell TypeResolutionPathway InteractionsGene ExpressionGenesBrainPredictive ModelingFunctional GenomicsRegulatory ElementQuality Of LifeGenomic DataImpaired CognitionSeveritiesBrain TissueGene Expression ProfileDiagnosisLeadNeuropathologyCostHigh Dimensionality
Grant awards (19)
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,833,218
R01 · FY2023 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$421,204
R01 · FY2023 · AG
Creation of a Schwann Cell Gene Regulatory Network$181,055
R21 · FY2023 · NS
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,833,217
R01 · FY2022 · AG
Machine learning analyses of single-cell multi-modal data for understanding cell-type functional genomics and gene regulation$1,219,630
RF1 · FY2022 · MH · contact PI
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$441,355
R01 · FY2022 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$422,046
R01 · FY2022 · AG
Prediction and Validation of Oligodendrocyte Gene Regulatory Network from Multi-Omics$400,985
R21 · FY2022 · NS
Creation of a Schwann Cell Gene Regulatory Network$219,930
R21 · FY2022 · NS
Determining the neurodevelopmental cell type specific regulatory networks impacted in Down syndrome$98,300
R03 · FY2022 · NS
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,831,622
R01 · FY2021 · AG
Determining the neurodevelopmental cell type specific regulatory networks impacted in Down syndrome$366,125
R03 · FY2021 · NS
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$253,798
R01 · FY2021 · AG
A new bladder cancer model based on tissue reprogramming and gene targeting$181,790
R21 · FY2021 · CA
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,875,015
R01 · FY2020 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$436,643
R01 · FY2020 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$250,000
R01 · FY2020 · AG
A new bladder cancer model based on tissue reprogramming and gene targeting$219,073
R21 · FY2020 · CA
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,925,544
R01 · FY2019 · AG